The authors examine the effectiveness of an excipient comprised of mannitol, polyvinyl acetate, and crospovidone using model actives loperamide hydrogen chloride and caffeine.
A Maschke
Advertisement
A. Maschke, PhD, is a R&D manager, BASF
Articles by A Maschke
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
3
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
4
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
5